Q3 2016 Holdings
Filed 2016-10-24 | 7 holdings | $89.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Audentes Therapeutics, Inc.(BOLDEUR) | Common Stock | 05070R104 | $32.2M | 1,806,832 | 35.9% |
| Immune Design Corp. | Common Stock | 45252L103 | $16.7M | 2,208,210 | 18.7% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $15.2M | 2,215,384 | 17.0% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $14.7M | 407,416 | 16.4% |
| Achaogen, Inc. | Common Stock | 004449104 | $6.1M | 1,281,152 | 6.8% |
| Glaukos Corporation(GKOS) | Common Stock | 377322102 | $2.7M | 71,428 | 3.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $2.0M | 1,048,601 | 2.3% |